Int J Cancer. 2017 Oct 9. doi: 10.1002/ijc.31091. [Epub ahead of print]
Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study.
Heong V1,2, Syn NL1,2, Lee XW1, Sapari NS2, Koh XQ2, Adam Isa ZF2, Lim JS2, Lim D3,4, Pang B2,3,4, Thian YL5, Ng LK3, Wong AL1,2, Soo RA1,2, Yong WP1,2, Chee CE1, Lee SC1,2, Goh BC1,2,6, Soong R2,3, Tan DSP1,2,7.
© 2017 UICC.
Biomarker-driven clinical trials; Next-generation sequencing; Precision Medicine; Precision oncology; Targeted therapy